Background There is increasing recognition of a prothrombotic state in COVID-19. Post-mortem
examination can provide important mechanistic insights. Methods We present a COVID-…

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is characterized by respiratory distress, multiorgan dysfunction, …

Objective Heightened inflammation, dysregulated immunity, and thrombotic events are
characteristic of hospitalized COVID‐19 patients. Given that platelets are key regulators of …

Background There is a paucity of data describing the effects of coronavirus disease 2019 on
placental pathology, especially in asymptomatic patients. Although the pathophysiology of …

Given the evidence for a hyperactive platelet phenotype in COVID-19, we investigated
effector cell properties of COVID-19 platelets on endothelial cells (ECs). Integration of EC and …

Introduction We describe post‐mortem pulmonary histopathologic findings of COVID‐19
pneumonia in patients with a spectrum of disease course, from rapid demise to prolonged …

Patients with coronavirus disease 2019 (COVID-19) present increased risk for ischemic
cardiovascular complications up to 1 year after infection. Although the systemic inflammatory …

Effective public response to a pandemic relies upon accurate measurement of the extent and
dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach …

Although coronavirus disease 2019 (COVID-19) is transmitted via respiratory droplets, there
are multiple gastrointestinal and hepatic manifestations of the disease, including abnormal …

… Amy V. Rapkiewicz reports payment for expert testimony by Eric Hack, Esq. Bruno Märkl
reports grants or contracts from the German Registry of COVID-19 Autopsies, funded by the …